Advertisement

Journal of Assisted Reproduction and Genetics

, Volume 31, Issue 2, pp 199–203 | Cite as

Ovarian sensitivity index is a better measure of ovarian responsiveness to gonadotrophin stimulation than the number of oocytes during in-vitro fertilization treatment

  • Hang Wun Raymond LiEmail author
  • Vivian Chi Yan Lee
  • Pak Chung Ho
  • Ernest Hung Yu Ng
Assisted Reproduction Technologies

Abstract

Purpose

To validate the use of the ovarian sensitivity index (OSI) as a measure of ovarian response during in-vitro fertilization (IVF) treatment.

Methods

This is a retrospective study carried out in an assisted reproduction unit in a teaching hospital. We analysed data from 2,556 women undergoing the first IVF cycle between 2002 and 2009. OSI was calculated as the number of retrieved oocytes divided by total dose of FSH administered (per 1,000 IU). Its correlation to other parameters of ovarian response was compared to that of the oocyte number.

Results

The correlation coefficients of OSI with age, AFC, AMH, total dose of gonadotrophin, average daily dose of gonadotrophin and duration of stimulation were significantly higher than that of oocyte number with these respective parameters. OSI demonstrated a higher intraclass correlation coefficient (ICC) than the oocyte number when comparing the two parameters across the first and second stimulated IVF cycles.

Conclusions

OSI is a better measure of ovarian responsiveness to gonadotrophin stimulation than the oocyte number, and is particularly useful when different subjects are treated with different stimulation regimens which would have confounding effect on the oocyte number.

Keywords

In-vitro fertilization Ovarian response Ovarian sensitivity index Ovarian stimulation 

Notes

Acknowledgments

The authors would like to thank Mr. Tak-Ming Cheung, Ms. Sharon Lee and Ms. Emily So for assistance in data retrieval.

References

  1. 1.
    Li HWR, Lee VCY, Lau EYL, Yeung WSB, Ho PC, Ng EHY. Role of baseline antral follicle count and anti-mullerian hormone in prediction of cumulative live birth in the first in vitro fertilisation cycle: a retrospective cohort analysis. PLoS One. 2013;8(4):e61095.PubMedCentralPubMedCrossRefGoogle Scholar
  2. 2.
    Delvigne A. Epidemiology of OHSS. Reprod Biomed Online. 2009;19(1):8–13.PubMedCrossRefGoogle Scholar
  3. 3.
    Ng EHY. Adverse effects of excessive ovarian response on the pregnancy rate of in vitro fertilization treatment. Gynecol Endocrinol. 2009;25(1):2–7.PubMedCrossRefGoogle Scholar
  4. 4.
    Sunkara SK, Rittenberg V, Raine-Fenning N, Bhattacharya S, Zamora J, Coomarasamy A. Association between the number of eggs and live birth in IVF treatment: an analysis of 400 135 treatment cycles. Hum Reprod. 2011;26(7):1768–74.PubMedCrossRefGoogle Scholar
  5. 5.
    Biasoni V, Patriarca A, Dalmasso P, Bertagna A, Manieri C, Benedetto C, et al. Ovarian sensitivity index is strongly related to circulating AMH and may be used to predict ovarian response to exogenous gonadotropins in IVF. Reprod Biol Endocrinol. 2011;9:112.PubMedCentralPubMedCrossRefGoogle Scholar
  6. 6.
    Broer SL, Mol BWJ, Hendriks D, Broekmans FJM. The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count. Fertil Steril. 2009;91(3):705–14.PubMedCrossRefGoogle Scholar
  7. 7.
    Broer SL, Dolleman M, Opmeer BC, Fauser BC, Mol BW, Broekmans FJ. AMH and AFC as predictors of excessive response in controlled ovarian hyperstimulation: a meta-analysis. Hum Reprod Update. 2011;17(1):46–54.PubMedCrossRefGoogle Scholar
  8. 8.
    Yong PY, Brett S, Baird DT, Thong KJ. A prospective randomized clinical trial comparing 150 IU and 225 IU of recombinant follicle-stimulating hormone (Gonal-F) in a fixed-dose regimen for controlled ovarian stimulation in in vitro fertilization treatment. Fertil Steril. 2003;79:308–15.PubMedCrossRefGoogle Scholar
  9. 9.
    Jayaprakasan K, Hopkisson J, Campbell B, Johnson I, Thornton J, Raine_Fenning N. A randomised controlled trial of 300 versus 225 IU recombinant FSH for ovarian stimulation in predicted normal responders by antral follicle count. BJOG. 2010;117:853–62.PubMedCrossRefGoogle Scholar
  10. 10.
    La Marca A, Grisendi V, Giulini S, Argento C, Tirelli A, Dondi G, et al. Individualization of the FSH starting dose in IVF/ICSI cycles using the antral follicle count. J Ovarian Res. 2013;6:11.PubMedCentralPubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Hang Wun Raymond Li
    • 1
    Email author
  • Vivian Chi Yan Lee
    • 1
  • Pak Chung Ho
    • 1
  • Ernest Hung Yu Ng
    • 1
  1. 1.Centre of Assisted Reproduction and Embryology, Department of Obstetrics and GynaecologyThe University of Hong Kong, Queen Mary HospitalHong KongHong Kong

Personalised recommendations